Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2017–2022 · research · R01
Inhibition of brain metastasis by blocking MAPK12 driver kinase functions
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Role of response regulator phosphorylation in group A streptococcal pathogenesis
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Role of the Histone Modifier KDM2A in Lung Cancer
Min Gyu Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Georgios Karras · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · research · R01
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R35
Harnessing the power of exosomes for non-coding RNA delivery
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
imaging Radiation-Associated Dysphagia (iRAD)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Mechanistic Roles of Long Non-Coding RNA in Glioblastoma Development and Treatment
Suyun Huang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · research · R50
Instituting innovative CRISPR/Cas9 technology at an NCI Comprehensive Cancer Center transgenic facility
Jan Parker-Thornburg · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The roles of TRIM24 in breast cancer
Michelle Ann Barton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Instituting innovative CRISPR/Cas9 technology at an NCI Comprehensive Cancer Center transgenic facility
Jan Parker-Thornburg · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · cooperative agreement · U01
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Signature-guided therapy for mismatch repair defective cancers
Shiaw-Yih Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Prevention
Active Living After Cancer: Combining a Physical Activity Program with Survivor Navigation
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · research · R01
Define redundant functions of H2AX and NBS1 in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients
David Hui · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2018 · career development · K00
Cancer Prevention: Staging my career as a cancer biologist
Heather Graham Hambright · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · CPRIT Scholar
Recruitment of Established Investigators
Yair Reisner · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2020 · research · R01
Signaling Mechanisms of Opioid-Induced Hyperalgesia and Tolerance
Hui-Lin Pan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · fellowship · F31
Identification of a key transcriptional regulator of AT1 cell development and maintenance
Danielle R Little · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2028 · program · P40
Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR)
William D Hopkins · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Molecular Determinants of Synaptic Plasticity in Chronic Pain
Shao-Rui Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P50
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P20
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
Lorna H. Mcneill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Novel regulations of DNA damage repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Cell Cycle Blockade and Therapeutic Sensitization
Zahid H Siddik · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Uncovering Gene Expression Differences between Benign and Premalignant Colorectal Polyps
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR)
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Instituting innovative CRISPR/Cas9 technology at an NCI Comprehensive Cancer Center transgenic facility
Jan Parker-Thornburg · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling
Gabriel Lopez-Berestein · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Molecular Mechanisms Underlying Environmental Effects that Influence Penetrance in Lynch Syndrome-Associated Endometrial Cancer
Melinda S. Yates · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R03
A Novel Mouse Model for Uterine Leiomyoma
Kwong Kwok Wong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R03
Improving dose coverage of tumor periphery in radiotherapy of lung cancer through the use of flattening filter free beams
Oleg Vassiliev · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
University of Texas PDX Development and Trial Center
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · Grant-in-Aid
Substance P antagonism for prevention of chemotherapy associated cardiotoxicity.
Prema Robinson · The University of Texas MD Anderson Cancer Center · funded by American Heart Association
2017–2024 · research · R01
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Role of HDAC8 and higher order chromatin structure in melanoma metastasis and therapy
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · research · R01
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
MSC-Derived Exosomes and MicroRNA in Glioma Therapy
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
Rosa F. Hwang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
